FEZF1 and pancreatic ductal adenocarcinoma: Notably, FEZF1-AS1 showed tumor-promoting ability in other tumors like gastric tumors, non-small cell lung cancer, and pancreatic ductal adenocarcinoma (PDAC), which indicated that FEZF1-AS1 might serve as an index in tumor detection [18,19,55].